Trending...
- Rising Stars Romulus First Debuts Genre-Bending Album "Reality"
- L.A. County Board of Supervisors Recognizes Amapola Market for Outstanding Community Philanthropy
- InventHelp Inventor Develops Improved Litter Box Scoop (CCT-4921)
CINCINNATI, Feb. 7, 2024 ~ David Kroekel has been appointed as the new Chief Operating Officer of Enable Injections, a leading company in developing and manufacturing wearable drug delivery systems. In this critical position, Mr. Kroekel will be responsible for overseeing the ongoing engineering, manufacturing, and supply of the Company's enFuse technology.
According to Mike Hooven, Chairman and CEO of Enable Injections, "David brings a wealth of experience in cross-functional collaboration, infrastructure development, and engineering excellence in medical device manufacturing and development." He also added that Mr. Kroekel's leadership has played a pivotal role in the company's success so far.
With over 35 years of experience in medical device operations and product development, Mr. Kroekel is well-equipped to take on this new role at Enable Injections. Prior to joining the company, he served as the Biomedical Global Head of Operations at DSM Biomedical where he was responsible for global leadership of biologics and medical materials manufacturing. He also held senior positions at Flowonix Medical, Teleflex Medical, and Arrow International's EMEA business unit in Belgium.
More on Ohio Pen
Mr. Kroekel holds a Bachelor of Science in Mechanical Engineering from Pennsylvania State University and a Master of Science in Manufacturing Systems Engineering from Lehigh University.
In his new role as COO, Mr. Kroekel is excited to lead and advance how their manufacturing and product development teams can increase capabilities and efficiencies in delivering their wearable technology to more patients. He believes that enFuse is a breakthrough solution for meeting patient needs with its hands-free wearable technology that allows self-administration of large-volume medications without an IV or syringe pump.
This strategic leadership reinforcement comes after the recent U.S. FDA approval and launch of Enable's first enFuse combination product. The company is currently working with several pharmaceutical partners to conduct clinical trials and plan for joint commercial launch of their therapies using enFuse technology.
Enable continues to selectively add to its list of pharmaceutical partners, with indications and patient populations who will benefit from the enFuse system. With Mr. Kroekel's expertise and leadership, the company is poised for long-term commercial success and increasing product demand. The team at Enable is committed to driving innovation for enFuse and bringing this game-changing technology to their partners, healthcare professionals, and most importantly – patients.
According to Mike Hooven, Chairman and CEO of Enable Injections, "David brings a wealth of experience in cross-functional collaboration, infrastructure development, and engineering excellence in medical device manufacturing and development." He also added that Mr. Kroekel's leadership has played a pivotal role in the company's success so far.
With over 35 years of experience in medical device operations and product development, Mr. Kroekel is well-equipped to take on this new role at Enable Injections. Prior to joining the company, he served as the Biomedical Global Head of Operations at DSM Biomedical where he was responsible for global leadership of biologics and medical materials manufacturing. He also held senior positions at Flowonix Medical, Teleflex Medical, and Arrow International's EMEA business unit in Belgium.
More on Ohio Pen
- Axiros' Founder Gunther Klessinger Takes on CTO Role to Lead Axiros into a New Era of Technology
- Macy Alex Photography Hosts Art Showcase and Fundraiser Benefiting Giving Grace
- Clearstead Announces Bradley Knapp will become President and Chief Executive Officer
- ONI KAI NINJUTSU Opens Flagship Martial Arts Dojo in Pollock Pines, CA
- Safeguarding Your Shipments: A Data-Driven Approach
Mr. Kroekel holds a Bachelor of Science in Mechanical Engineering from Pennsylvania State University and a Master of Science in Manufacturing Systems Engineering from Lehigh University.
In his new role as COO, Mr. Kroekel is excited to lead and advance how their manufacturing and product development teams can increase capabilities and efficiencies in delivering their wearable technology to more patients. He believes that enFuse is a breakthrough solution for meeting patient needs with its hands-free wearable technology that allows self-administration of large-volume medications without an IV or syringe pump.
This strategic leadership reinforcement comes after the recent U.S. FDA approval and launch of Enable's first enFuse combination product. The company is currently working with several pharmaceutical partners to conduct clinical trials and plan for joint commercial launch of their therapies using enFuse technology.
Enable continues to selectively add to its list of pharmaceutical partners, with indications and patient populations who will benefit from the enFuse system. With Mr. Kroekel's expertise and leadership, the company is poised for long-term commercial success and increasing product demand. The team at Enable is committed to driving innovation for enFuse and bringing this game-changing technology to their partners, healthcare professionals, and most importantly – patients.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Work 365 Now Available on Pax8 Marketplace, Empowering MSPs with Enhanced CSP Management
- OCLC is among Computerworld's 'Best Places to Work in IT' for the 16th year
- VerifyTreatment Expands Its Salesforce Functionality with Cyntexa's Expertise
- Events by Dubsdread Offerings Go Beyond Weddings
- Alley Cat Allies Files Lawsuit To Stop the Illegal Killing of Cats in Summit County, Ohio
- Century Fasteners Corp. Receives Accreditation to AS9120B Quality Management Systems
- Material Capital Partners Closes Financing for 170-Unit Build-For-Rent Community in Brunswick, Georgia
- Local Clevelander Wins $500,000 on Scratcher Using Jackpot.com
- The Computer Works Secures Growth Capital to Expand Fiber Connectivity
- New Release: Kannazuki, Vol. 1: The Beast Of Akune Shakes Up the Fantasy Genre!
- Now Shipping Epson ColorWorks CW-C8000 Color Label Printers Across the USA and Canada
- Purfresh Clean launches its new "SPACE" product - An innovative technology restaurants are using to get rid of their rat and mice problems
- The Ergo Company presents Old Righteous Blues A Compelling South African Tale
- L.A. County Board of Supervisors Recognizes Amapola Market for Outstanding Community Philanthropy
- Master P Hosts the First Major Hip-Hop Black History Month Benefit Concert at NJPAC
- Milford Massage Therapist Named Among Top 5 Brazilian Lymphatic Massage Therapists
- Paddy Power Teams Up with Our Price in Their First-Ever Christmas Ad
- Greenhouse Temperature Monitoring Protects Sensitive Flowers
- RESA Power Expands and Enhances its Transformer Services Capabilities with the Acquisition of Power Asset Recovery Corporation
- Restoring the Legacy - Bimini's Since 1975